Aller au contenu principal
2025 article

Protective Role of Maternal Antibodies Against SARS-CoV-2 in Infants Six Months or Younger: An Observational Study

0Citations signalées — pas une note de qualité
4Institutions déclarées
2Pays d’affiliation déclarés

Résumé fourni par la source

BACKGROUND: Maternal humoral immunity appears to confer protection to infants against SARS-CoV-2. However, data comparing the protective effect of naturally acquired versus vaccine-induced maternal immunity in infants remain limited. METHODS: A retrospective observational study was conducted in infants ≤6 months of age with suspected infection between January 2021 and September 2024. The sample was divided into those with confirmed SARS-CoV-2 infection and those with a negative microbiological result for the virus. The association between maternal serology (anti-S1-RBD IgG), the origin of maternal immunity and symptomatic SARS-CoV-2 infection in infants was analyzed, adjusting for infant age and month of infection. RESULTS: A total of 244 infants were included, of whom 22% had confirmed SARS-CoV-2 infection. Anti-S1-RBD IgG antibodies were detected in 76.2% of mothers, and their presence was associated with a lower risk of infection in infants [relative risks (RR): 0.459; 95% confidence interval (95% CI): 0.284-0.744; P = 0.002]. Naturally acquired immunity showed a stronger protective effect (RR: 0.397; 95% CI: 0.213-0.744; P = 0.004) compared with vaccine-induced immunity (RR: 0.558; 95% CI: 0.325-0.958; P = 0.034). Maternal antibody titers demonstrated limited predictive capacity for infant protection (area under the curve = 0.699), with an optimal threshold of 109.50 BAU/mL (sensitivity 68.5%, specificity 73%). CONCLUSIONS: The presence of maternal anti-S1-RBD IgG antibodies was associated with a lower risk of SARS-CoV-2 infection in infants ≤6 months old, with a more pronounced effect from natural maternal immunity. However, its predictive value was limited, suggesting that additional immunological factors may contribute to infant susceptibility.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Protective Role of Maternal Antibodies Against SARS-CoV-2 in Infants Six Months or Younger: An Observational Study
Date Crossref
17/12/2025
Éditeur
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

COVID-19 Impact on ReproductionSARS-CoV-2 and COVID-19 ResearchReproductive System and Pregnancy

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.